Asymptomatic Crohn’s disease identified in a patient being treated with secukinumab: A case report

IL-17 antagonism is among the most potent treatments for psoriasis. Generally safe, new onset and exacerbations of inflammatory bowel disease may occur in association with IL-17 therapy. We describe a patient with long-standing history of psoriasis and psoriatic arthritis in whom asymptomatic Crohn’...

Descripción completa

Detalles Bibliográficos
Autores principales: Haidari, Wasim, Al-Naqshabandi, Sarah, Ahn, Christine S, Bloomfeld, Richard S, Feldman, Steven R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
JCMS Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900620/
https://www.ncbi.nlm.nih.gov/pubmed/31839950
http://dx.doi.org/10.1177/2050313X19893580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900620/
https://www.ncbi.nlm.nih.gov/pubmed/31839950
http://dx.doi.org/10.1177/2050313X19893580

Ejemplares similares